Latest news with #financialreport
Yahoo
9 hours ago
- Business
- Yahoo
Novem Group Full Year 2025 Earnings: Revenues In Line With Expectations
Revenue: €541.5m (down 15% from FY 2024). Net income: €11.1m (down 68% from FY 2024). Profit margin: 2.0% (down from 5.5% in FY 2024). The decrease in margin was driven by lower revenue. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue was in line with analyst estimates. The primary driver behind last 12 months revenue was the Americas segment contributing a total revenue of €280.8m (52% of total revenue). The largest operating expense was General & Administrative costs, amounting to €148.9m (57% of total expenses). Explore how NVM's revenue and expenses shape its earnings. Looking ahead, revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 2.6% growth forecast for the Auto Components industry in Germany. Performance of the German Auto Components industry. The company's shares are down 1.4% from a week ago. Before you take the next step you should know about the 2 warning signs for Novem Group (1 is a bit unpleasant!) that we have uncovered. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a day ago
- Business
- Yahoo
Concentrix Corp (CNXC) Q2 2025 Earnings Call Highlights: Navigating Growth Amidst Operational ...
Revenue: Approximately $2.4 billion, an increase of 1.5% year on year. Non-GAAP Operating Income: $304 million, below the guidance range. Adjusted EBITDA: $357 million, with a margin of 14.8%. Non-GAAP Diluted EPS: $2.70 per share, within guidance range. GAAP Net Income: $42 million. GAAP Diluted EPS: $0.63 per share. Adjusted Free Cash Flow: $200 million. Cash and Cash Equivalents: $343 million. Total Debt: Approximately $4.9 billion. Net Debt: $4.5 billion. Share Repurchases: $45 million, approximately 920,000 shares at an average price of $49 per share. Quarterly Dividend: $22 million. Third Quarter Revenue Guidance: $2.445 billion to $2.470 billion. Full Year Revenue Guidance: $9.720 billion to $9.815 billion. Full Year Non-GAAP EPS Guidance: $11.53 to $11.76 per share. Adjusted Free Cash Flow Guidance: $625 million to $650 million. Warning! GuruFocus has detected 4 Warning Signs with CNXC. Release Date: June 26, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Concentrix Corp (NASDAQ:CNXC) reported solid revenue growth, exceeding guidance with approximately $2.4 billion in revenue, marking a 1.5% year-on-year increase. The company is seeing strong momentum in its AI-led customer experience offerings and adjacent AI solutions, which are growing faster than the core business. Concentrix Corp (NASDAQ:CNXC) launched iX Hero, an AI-powered application, complementing its autonomous AI assistant product, iX Hello, and is gaining early market traction. The company is benefiting from partner consolidation, allowing it to win new business with more complex and scalable services. Concentrix Corp (NASDAQ:CNXC) has a strong pipeline and expects continued revenue growth, driven by broad-based momentum across geographies and verticals, including banking, tech, media, and healthcare. Operational margins were lighter than anticipated due to holding labor during client project pauses and preparing for accelerated growth. Non-GAAP operating income was below guidance due to client program pauses related to tariffs and elevated investments for future growth. The company faced a mixed impact from foreign exchange rates, which were a headwind for profitability despite being a tailwind for revenue. There is a 2% headwind from work moving offshore, impacting revenue growth and causing temporary duplication of costs. The operating margin guidance for the full year is lower by 40 basis points, reflecting challenges in maintaining profitability amid revenue growth. Q: Is the revenue acceleration in the second half broad-based or reliant on specific contracts? A: Christopher Caldwell, President and CEO, stated that the momentum is broad-based across geographies and verticals, including banking, tech, media, and healthcare. The deals being won are more complex and involve their technology, which is a strategic focus for the company. Q: How is AI impacting Concentrix's market position and future expectations? A: Christopher Caldwell explained that Concentrix's AI solutions, including their iX suite, are gaining traction. Clients are adopting these solutions faster than expected, and the company is seeing economic returns. The AI initiatives are expected to be accretive by the end of Q4, with continued growth without additional investment. Q: What caused the Q2 margins to be below guidance, and how will they improve? A: Christopher Caldwell noted that margins were impacted by a temporary pause in client projects due to tariffs. The company chose to hold labor, which was strategic for client relationships. Margins began improving in May, and further improvement is expected in Q3 as projects resume. Q: What is the outlook for operating margins and revenue growth in the second half? A: Andre Valentine, CFO, expressed confidence in margin improvement due to new business ramping up and additional client share gained. The company expects sequential margin improvement and is focused on achieving the higher end of their revenue guidance. Q: How is Concentrix's pricing strategy evolving with AI and automation? A: Christopher Caldwell mentioned that while there is interest in outcomes-based pricing, most deals still follow traditional transactional models. The company is focused on growing new revenue streams, such as their iX product suite, which includes discrete software-like revenue. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Zawya
a day ago
- Business
- Zawya
Saudi: Sipchem unveils $96.66mln cash dividends for H1-25
Riyadh – The board of Sahara International Petrochemical Company (Sipchem) announced cash dividends worth SAR 362.56 million, equivalent to 5% of its share capital, for the first half (H1) of 2025. Sipchem will pay SAR 0.50 per share for 725.12 million eligible shares, according to a bourse disclosure. Eligibility and disbursement dates for the H1-25 dividends will be 3 and 17 July 2025, respectively. During the first three months (3M) of 2025, the Saudi company registered an annual rise of 7.60% in net profit to SAR 195.30 million, compared to SAR 181.50 million. All Rights Reserved - Mubasher Info © 2005 - 2022 Provided by SyndiGate Media Inc. (
Yahoo
2 days ago
- Business
- Yahoo
Enerpac: Fiscal Q3 Earnings Snapshot
MENOMONEE FALLS, Wis. (AP) — MENOMONEE FALLS, Wis. (AP) — Enerpac Tool Group Corp. (EPAC) on Thursday reported earnings of $22 million in its fiscal third quarter. The Menomonee Falls, Wisconsin-based company said it had profit of 41 cents per share. Earnings, adjusted for one-time gains and costs, came to 51 cents per share. The industrial products company posted revenue of $158.7 million in the period. Enerpac expects full-year revenue in the range of $610 million to $625 million. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on EPAC at
Yahoo
2 days ago
- Business
- Yahoo
Compared to Estimates, Walgreens (WBA) Q3 Earnings: A Look at Key Metrics
Walgreens Boots Alliance (WBA) reported $38.99 billion in revenue for the quarter ended May 2025, representing a year-over-year increase of 7.3%. EPS of $0.38 for the same period compares to $0.63 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $36.61 billion, representing a surprise of +6.49%. The company delivered an EPS surprise of +11.76%, with the consensus EPS estimate being $0.34. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately. Here is how Walgreens performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenues- U.S. Retail Pharmacy: $30.72 billion compared to the $28.76 billion average estimate based on four analysts. The reported number represents a change of +7.8% year over year. Revenues- U.S. Healthcare: $2.10 billion versus $2.17 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -1.1% change. Revenues- International: $6.17 billion versus the four-analyst average estimate of $5.74 billion. The reported number represents a year-over-year change of +7.8%. Adjusted operating income (loss)- U.S. Retail Pharmacy: $350 million versus the two-analyst average estimate of $113.67 million. Adjusted operating income (loss)- Corporate and Other: -$60 million versus the two-analyst average estimate of -$52.50 million. Adjusted operating income (loss)- U.S. Healthcare: $54 million versus the two-analyst average estimate of $72.85 million. Adjusted operating income (loss)- International: $214 million versus $196.39 million estimated by two analysts on average. View all Key Company Metrics for Walgreens here>>>Shares of Walgreens have returned +1.1% over the past month versus the Zacks S&P 500 composite's +5.1% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Walgreens Boots Alliance, Inc. (WBA) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
